10 Toxicity section, please fix unsubstantiated claim of psoriasis induction by taurine.8 Regarding claims under physiological functions.2 Content Request: Use in energy drinks.1 Content Request: Use in energy drink naming.This article has not yet received a rating on the importance scale. This article has been rated as B-Class on the quality scale. Molecular Biology Wikipedia:WikiProject Molecular Biology Template:WikiProject Molecular Biology Molecular Biology articles If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks. This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. Pharmacology Wikipedia:WikiProject Pharmacology Template:WikiProject Pharmacology pharmacology articles This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. This article has been rated as Mid-importance on the project's importance scale. This article has been rated as B-Class on the project's quality scale. Chemicals Wikipedia:WikiProject Chemicals Template:WikiProject Chemicals chemicals articles To participate, help improve this article or visit the project page for details on the project. This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. This article is of interest to the following WikiProjects: Editors may also seek a reassessment of the decision if they believe there was a mistake. Once these issues have been addressed, the article can be renominated. There are suggestions below for improving the article to meet the good article criteria. Taurine was one of the Natural sciences good articles, but it has been removed from the list. This article has been rated as B-Class by the WikiProject Vital Articles. Taurine has been listed as a level-5 vital article in Science, Chemistry.
0 kommentar(er)
